Correction: SGLT2-inhibitors in Diabetic Patients with Severe Aortic Stenosis and Cardiac Damage Undergoing Transcatheter Aortic Valve Implantation (TAVI)
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Aortic Stenosis Prevention: Is a New Cardiovascular Disease Paradigm Coming of Age?.
Halapas A, Cokkinos D J Clin Med. 2025; 14(3).
PMID: 39941574 PMC: 11818457. DOI: 10.3390/jcm14030903.
References
1.
Paolisso P, Belmonte M, Gallinoro E, Scarsini R, Bergamaschi L, Portolan L
. SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI). Cardiovasc Diabetol. 2024; 23(1):420.
PMC: 11583434.
DOI: 10.1186/s12933-024-02504-8.
View